Evidence-based, stepped care of ADHD in school-aged children between 6-11 years (ESCAschool)

Phase 4

• Conditions: F90; Hyperkinetic disorders

• Registration Number: DRKS00008973
• Lead Sponsor: niversitätsklinikum Köln

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-12-18
• Study Completion: 2020-04-23
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 523

Inclusion Criteria

Attending of school (including special schools); Meeting criteria for ADHD according to DSM-5; Informed consent of guardians and child assent

Exclusion Criteria

IQ below average (IQ<80), diagnosis of pervasive developmental disorder, schizophrenia, bipolar disorder, severe depressive episode, epilepsy, heart disease, current or planned intensive behavioural therapy for ADHD or oppositional behavior on a weekly basis, for children with severe ADHD known non-response to all standard ADHD medication (methylphenidate,dexamphenidate, atomoxetine) psychotropic medication (other than for ADHD) or neuroleptic medication (other than for the treatment of disturbance of impulse control), insufficent German language and reading skills of participating parent

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Primary outcome is the blinded clinician-rated total score of the ADHD-Checklist (DCL-ADHS) based on parent interview.<br><br>For children with mild to moderate ADHD analysis of the randomized between-group comparison in step 1 (arm 2 vs. arm 3 with the assessments T1 and T2b/T2c1).<br><br>For children with severe ADHD and partial response to treatment in step 1 analysis of the randomized between-group comparison of corresponding interventions in step 2 (arm 5 vs. arm 6 vs. arm 7 with the assessments T2a and T3b/T3c/T3d).